In contrast, in cervical cancer studies, nicotinamide adenine dinucleotide (NAD+) metabolic models have shown that high expression of CGREF1 is associated with poor prognosis(Chen et al. 2022). This evidence concerns the gene CGREF1 and cervical carcinoma.